Difference between revisions of "Emergent Biosolutions Inc"
(basic page created) |
(No difference)
|
Revision as of 15:22, 31 October 2013
Contents
Background
Emergent BioSolutions (NYSE: EBS) is a multinational specialty biopharmaceutical company headquartered in Rockville, Maryland. It develops vaccines and therapeutics for infectious diseases, oncology and autoimmune disorders.
People
- Michael Milligan - Secretary General
- Thomas Barmüller - Director EMEA
- Aderbal Bonturi Pereira - Latin America Director
- Sabine Lobnig - Communications & Regulatory Officer
Affiliations
- Emergent Biosolutions Inc was a donor to the Science Media Centre in 2010 and 2011 according to the SMC.[1]
Contact
- Corporate
- 2273 Research Boulevard
- Suite 400
- Rockville, MD 20850
- USA
- Tel: 301-795-1800
- Fax: 301-795-1899
Notes
- ↑ Data from Internet Archive holdings of the Science Media Centre website, 2002-2013. May 2010 http://web.archive.org/web/20100822091312/http://www.sciencemediacentre.org/pages/about/funding.htm Jun 2011 http://web.archive.org/web/20110807075127/http://www.sciencemediacentre.org/pages/about/funding.htm
